Researchers said Watson provided actionable insights within 10 minutes, compared to 160 hours of human analysis and curation typically required to reach similar conclusions.
The potential for artificial intelligence in precision medicine is big, according to conclusions of a new study by the New York Genome Center and IBM.
The results, published in the July 11 issue of Neurology Genetics…showed that researchers at the New York Genome Center, Rockefeller University and other institutions – along with IBM – verified the potential of IBM Watson for Genomics to analyze complex genomic data from state-of-the-art DNA sequencing of whole genomes.
This informatics challenge is often a critical bottleneck when dealing with deadly cancers such as glioblastoma, with a median survival of less than 15 months following diagnosis, researchers noted.
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: AI can speed up precision medicine, New York Genome Center-IBM Watson study shows